Director, Business Development
NateraSalary not specified
- Full Time
- Mid-level (3 to 4 years), Senior (5 to 8 years)
Illumina
Associate Director, Business Development, Genomic Access - AI, Genomics & Drug Discovery
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, GenomicsIndustries
Requirements
Candidates should possess a Bachelor’s degree and have at least 7 years of experience in business development, with a focus on strategic partnerships and deal execution, particularly within the biopharmaceutical industry. Strong knowledge of genomics, drug discovery, and AI technologies is required, along with experience in managing strategic drug discovery deals from inception to closure and established relationships with biopharma companies.
Responsibilities
The Associate Director, Business Development, Drug Discovery will lead business development activities by leveraging genomic data into new revenue streams, identify and execute on potential revenue opportunities in AI, genomics, and drug discovery, develop and refine the strategic roadmap for genomics and target discovery services, interface closely with Illumina’s R&D team, manage deal flow end-to-end including negotiating agreements, present business plans and proposals, and provide mentorship to others while coordinating cross-functional stakeholders. Additionally, the role may require supporting large-scale genomics programs and traveling internationally up to 30%.
Skills
Genomics
Drug Discovery
Bioinformatics
Data Partnerships
Strategic Business Relationships
Biopharma Industry Knowledge
Genetic Target Discovery
Deal Management
Illumina
Supports genomics startups through funding and resources
About Illumina
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.
Key Metrics
San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees